Sections 505(b), (i) and 526 of the Federal Food, Drug, and Cosmetic Act, referred to in subsecs. (b)(2)(A) and (d)(1), (2)(B), are classified to sections 355(b), (i) and 360bb, respectively, of Title 21, Food and Drugs.
Section 351 of the Public Health Service Act, referred to in subsec. (b)(2)(A)(ii)(II), is classified to section 262 of Title 42, The Public Health and Welfare.
2018—Subsec. (b)(2)(A)(ii)(II). Pub. L. 115–141, § 401(a)(17), substituted “, and” for “; and”.
Subsec. (d)(2). Pub. L. 115–141, § 401(d)(1)(D)(iii), struck out subpar. (A) designation and heading, redesignated cls. (i) and (ii) of former subpar. (A) as subpars. (A) and (B), respectively, realigned margins, and struck out former subpar. (B) which related to special limitation for corporations to which former section 936 applied.
2017—Subsec. (a). Pub. L. 115–97 substituted “25 percent” for “50 percent”.
2015—Subsec. (b)(1)(D). Pub. L. 114–113 struck out subpar. (D). Text read as follows: “If section 41 is not in effect for any period, such section shall be deemed to remain in effect for such period for purposes of this paragraph.”
2014—Subsec. (b)(1)(D). Pub. L. 113–295 amended subpar. (D) generally. Prior to amendment, text read as follows: “For purposes of this paragraph, section 41 shall be deemed to remain in effect for periods after
2013—Subsec. (b)(1)(D). Pub. L. 112–240 substituted “
2010—Subsec. (b)(1)(D). Pub. L. 111–312 substituted “
2008—Subsec. (b)(1)(D). Pub. L. 110–343 substituted “
2006—Subsec. (b)(1)(D). Pub. L. 109–432 substituted “2007” for “2005”.
2004—Subsec. (b)(1)(D). Pub. L. 108–311 substituted “
1999—Subsec. (b)(1)(D). Pub. L. 106–170 substituted “
1998—Subsec. (b)(1)(D). Pub. L. 105–277 substituted “
1997—Subsec. (b)(1)(D). Pub. L. 105–34, § 601(b)(2), substituted “
Subsec. (b)(2)(A)(ii)(II). Pub. L. 105–115 struck out “or 507” after “505(b)”.
Subsec. (e). Pub. L. 105–34, § 604(a), struck out subsec. (e) which read as follows:
“(e)
“(1) after
“(2) after
1996—Pub. L. 104–188, § 1205(a)(1), renumbered section 28 of this title as this section.
Subsec. (a). Pub. L. 104–188, § 1205(d)(1), substituted “For purposes of section 38, the credit determined under this section for the taxable year is” for “There shall be allowed as a credit against the tax imposed by this chapter for the taxable year”.
Subsec. (b)(1)(D). Pub. L. 104–188, § 1204(e), inserted “, and before
Subsec. (d)(2) to (5). Pub. L. 104–188, § 1205(d)(2), redesignated pars. (3) to (5) as (2) to (4), respectively, and struck out former par. (2) which read as follows: “
“(A) the regular tax (reduced by the sum of the credits allowable under subpart A and section 27), over
“(B) the tentative minimum tax for the taxable year.”
Subsec. (e). Pub. L. 104–188, § 1205(b), amended subsec. (e) generally. Prior to amendment, subsec. (e) read as follows: “
1993—Subsec. (b)(1)(D). Pub. L. 103–66, § 13111(a)(2), substituted “
Subsec. (e). Pub. L. 103–66, § 13111(b), substituted “
1991—Subsec. (b)(1)(D). Pub. L. 102–227, § 102(b), substituted “
Subsec. (e). Pub. L. 102–227, § 111(a), substituted “
1990—Subsec. (b)(1)(D). Pub. L. 101–508, § 11402(b)(2), substituted “
Subsec. (e). Pub. L. 101–508, § 11411, substituted “
1989—Subsec. (b)(1)(D). Pub. L. 101–239 substituted “1990” for “1989”.
1988—Subsec. (b)(1)(D). Pub. L. 100–647, § 4008(c)(1), substituted “1989” for “1988”.
Subsec. (b)(2)(A)(ii)(II). Pub. L. 100–647, § 1018(q)(1), amended subcl. (II) generally. Prior to amendment, subcl. (II) read as follows: “before the date on which an application with respect to such drug is approved under section 505(b) of such Act or, if the drug is a biological product, before the date on which a license for such drug is issued under section 351 of the Public Health Services Act, and”.
1986—Subsec. (b)(1). Pub. L. 99–514, § 231(d)(3)(A)(i), (iv), substituted “41” for “30” in subpars. (A), (B), and (D), and substituted “1988” for “1985” in subpar. (D).
Subsec. (b)(2)(A)(ii)(I). Pub. L. 99–514, § 1879(b)(1)(A), substituted “the date such drug” for “the date of such drug”.
Subsec. (b)(2)(A)(ii)(II). Pub. L. 99–514, § 1879(b)(1)(B), inserted “or, if the drug is a biological product, before the date on which a license for such drug is issued under section 351 of the Public Health Services Act”.
Subsec. (c). Pub. L. 99–514, § 231(d)(3)(A)(i), (ii), substituted “41” for “30” in pars. (1) and (2) and “41(b)” for “30(b)” in par. (2).
Subsec. (d)(1). Pub. L. 99–514, § 1879(b)(2), amended par. (1) generally. Prior to amendment, par. (1) read as follows: “For purposes of this section, the term ‘rare disease or condition’ means any disease or condition which occurs so infrequently in the United States that there is no reasonable expectation that the cost of developing and making available in the United States a drug for such disease or condition will be recovered from sales in the United States of such drug. Determinations under the preceding sentence with respect to any drug shall be made on the basis of the facts and circumstances as of the date such drug is designated under section 526 of the Federal Food, Drug, and Cosmetic Act.”
Subsec. (d)(2). Pub. L. 99–514, § 701(c)(2), amended par. (2) generally. Prior to amendment, par. (2) read as follows: “The credit allowed by this section for any taxable year shall not exceed the taxpayer’s tax liability for the taxable year (as defined in section 26(b)), reduced by the sum of the credits allowable under subpart A and section 27.”
Subsec. (d)(3)(B). Pub. L. 99–514, § 1275(c)(4), struck out “934(b) or” before “936” in heading and amended text generally. Prior to amendment, text read as follows: “No credit shall be allowed under this section with respect to any clinical testing conducted by a corporation to which section 934(b) applies or to which an election under section 936 applies.”
Subsec. (d)(4). Pub. L. 99–514, § 231(d)(3)(A)(iii), substituted “section 41(f)” for “section 30(f)”.
Subsec. (e). Pub. L. 99–514, § 232, substituted “1990” for “1987”.
1984—Pub. L. 98–369, § 471(c), renumbered section 44H of this title as this section.
Subsec. (b)(1)(A), (B), (D). Pub. L. 98–369, § 474(g)(1)(A), substituted “section 30” for “section 44F”.
Subsec. (c)(1). Pub. L. 98–369, § 474(g)(1)(A), substituted “section 30” for “section 44F”.
Subsec. (c)(2). Pub. L. 98–369, § 474(g)(1)(A), (B), substituted “section 30” for “section 44F” and “section 30(b)” for “section 44F(b)”.
Subsec. (d)(2). Pub. L. 98–369, § 612(e)(1), substituted “section 26(b)” for “section 25(b)”.
Pub. L. 98–369, § 474(g)(2), amended par. (2) generally, substituting “shall not exceed the taxpayer’s tax liability for the taxable year (as defined in section 25(b), reduced by the sum of the credits allowable under subpart A and section 27” for “shall not exceed the amount of the tax imposed by this chapter for the taxable year reduced by the sum of the credits allowable under a section of this subpart having a lower number or letter designation than this section, other than the credits allowable by sections 31, 39, and 43. For purposes of the preceding sentence, the term ‘tax imposed by this chapter’ shall not include any tax treated as not imposed by this chapter under the last sentence of section 53(a)”.
Subsec. (d)(4). Pub. L. 98–369, § 474(g)(1)(C), substituted “section 30(f)” for “section 44F(f)”.
Pub. L. 115–97, title I, § 13401(c),
Amendment by Pub. L. 114–113 applicable to amounts paid or incurred after
Amendment by Pub. L. 113–295 applicable to amounts paid or incurred after
Amendment by Pub. L. 112–240 applicable to amounts paid or incurred after
Amendment by Pub. L. 111–312 applicable to amounts paid or incurred after
Amendment by Pub. L. 110–343 applicable to amounts paid or incurred after
Amendment by Pub. L. 109–432 applicable to amounts paid or incurred after
Amendment by Pub. L. 108–311 applicable to amounts paid or incurred after
Amendment by Pub. L. 106–170 applicable to amounts paid or incurred after
Amendment by Pub. L. 105–277 applicable to amounts paid or incurred after
Amendment by section 601(b)(2) of Pub. L. 105–34 applicable to amounts paid or incurred after
Pub. L. 105–34, title VI, § 604(b),
Amendment by section 1204(e) of Pub. L. 104–188 applicable to taxable years ending after
Amendment by section 1205(a)(1), (b), (d)(1), (2) of Pub. L. 104–188 applicable to amounts paid or incurred in taxable years ending after
Pub. L. 103–66, title XIII, § 13111(c),
Pub. L. 102–227, title I, § 102(c),
Pub. L. 102–227, title I, § 111(b),
Pub. L. 101–508, title XI, § 11402(c),
Amendment by section 1018(q)(1) of Pub. L. 100–647 effective, except as otherwise provided, as if included in the provision of the Tax Reform Act of 1986, Pub. L. 99–514, to which such amendment relates, see section 1019(a) of Pub. L. 100–647, set out as a note under section 1 of this title.
Amendment by section 4008(c)(1) of Pub. L. 100–647 applicable to taxable years beginning after
Amendment by section 231(d)(3)(A) of Pub. L. 99–514 applicable to taxable years beginning after
Amendment by section 701(c)(2) of Pub. L. 99–514 applicable to taxable years beginning after
Amendment by section 1275(c)(4) of Pub. L. 99–514 applicable to taxable years beginning after
Pub. L. 99–514, title XVIII, § 1879(b)(3),
Amendment by section 474(g) of Pub. L. 98–369 applicable to taxable years beginning after
Amendment by section 612(e)(1) of Pub. L. 98–369, applicable to interest paid or accrued after
Pub. L. 97–414, § 4(d),
For provisions that nothing in amendment by section 401(d)(1)(D)(iii) of Pub. L. 115–141 be construed to affect treatment of certain transactions occurring, property acquired, or items of income, loss, deduction, or credit taken into account prior to
For applicability of amendment by section 701(c)(2) of Pub. L. 99–514 notwithstanding any treaty obligation of the United States in effect on
For provisions directing that if any amendments made by subtitle A or subtitle C of title XI [§§ 1101–1147 and 1171–1177] or title XVIII [§§ 1800–1899A] of Pub. L. 99–514 require an amendment to any plan, such plan amendment shall not be required to be made before the first plan year beginning on or after